Skip to main content
. 2023 May 5;2023(5):CD006103. doi: 10.1002/14651858.CD006103.pub8

Summary of findings 8. Varenicline versus e‐cigarettes for smoking cessation.

Varenicline versus e‐cigarettes for smoking cessation
Patient or population: people who continued to smoke tobacco following acute coronary syndrome
Setting: hospital
Intervention: varenicline
Comparison: e‐cigarettes
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI) № of participants
(studies) Certainty of the evidence
(GRADE) Comments
Risk with e‐cigarettes Corresponding risk with varenicline
Smoking abstinence at longest follow‐up (6+ months)
 
148 per 1000 481 per 1000
(179 to 1000)
RR 3.25
(1.21 to 8.71)
54
(1 study) ⊕⊝⊝⊝a,b
Very low
 
SAEs
 
Not estimable
(no events in analysis)
Not estimable
(no events in analysis)
Not estimable
(no events in analysis)
54
(1 study)    
Neuropsychiatric SAEs
 
Not estimable
(no events in analysis)
Not estimable
(no events in analysis)
Not estimable
(no events in analysis)
54
(1 study)    
Cardiac SAEs
 
Not estimable
(no events in analysis)
Not estimable
(no events in analysis)
Not estimable
(no events in analysis)
54
(1 study)    
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). The assumed risk in the comparison group is calculated as the median risk in control groups.

CI: confidence interval; RR: risk ratio; SAE: serious adverse event
GRADE Working Group grades of evidence
 
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

aDowngraded two levels because of imprecision: fewer than 150 events in the analysis.
bDowngraded one level because of risk of bias: sole study at high risk.